FR2293213A1 - Medicament antitumoral - Google Patents

Medicament antitumoral

Info

Publication number
FR2293213A1
FR2293213A1 FR7440005A FR7440005A FR2293213A1 FR 2293213 A1 FR2293213 A1 FR 2293213A1 FR 7440005 A FR7440005 A FR 7440005A FR 7440005 A FR7440005 A FR 7440005A FR 2293213 A1 FR2293213 A1 FR 2293213A1
Authority
FR
France
Prior art keywords
pasteur
broth
culture
antitumour
listeria monocytogenes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7440005A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HESSE JEAN
Original Assignee
HESSE JEAN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HESSE JEAN filed Critical HESSE JEAN
Priority to FR7440005A priority Critical patent/FR2293213A1/fr
Publication of FR2293213A1 publication Critical patent/FR2293213A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR7440005A 1974-12-06 1974-12-06 Medicament antitumoral Withdrawn FR2293213A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7440005A FR2293213A1 (fr) 1974-12-06 1974-12-06 Medicament antitumoral

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7440005A FR2293213A1 (fr) 1974-12-06 1974-12-06 Medicament antitumoral

Publications (1)

Publication Number Publication Date
FR2293213A1 true FR2293213A1 (fr) 1976-07-02

Family

ID=9145661

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7440005A Withdrawn FR2293213A1 (fr) 1974-12-06 1974-12-06 Medicament antitumoral

Country Status (1)

Country Link
FR (1) FR2293213A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135820A2 (fr) * 1983-08-26 1985-04-03 Chugai Seiyaku Kabushiki Kaisha Agent antitumoral
WO1987003202A1 (fr) * 1985-11-26 1987-06-04 Sibar Srl Fraction obtenue a partir de listeria monocytogenes presentant une activite therapeutique, son procede de preparation et composition pharmaceutique la contenant

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135820A2 (fr) * 1983-08-26 1985-04-03 Chugai Seiyaku Kabushiki Kaisha Agent antitumoral
EP0135820A3 (en) * 1983-08-26 1987-10-14 Chugai Seiyaku Kabushiki Kaisha Antitumor agent
WO1987003202A1 (fr) * 1985-11-26 1987-06-04 Sibar Srl Fraction obtenue a partir de listeria monocytogenes presentant une activite therapeutique, son procede de preparation et composition pharmaceutique la contenant
EP0230556A1 (fr) * 1985-11-26 1987-08-05 SIBAR Srl Fraction obtenue à partir de Listeria monocytogenes possédant une activité thérapeutique, procédé pour sa préparation et composition pharmaceutique la contenant

Similar Documents

Publication Publication Date Title
FR2293213A1 (fr) Medicament antitumoral
Zeckwer et al. BLOOD SUGAR STUDIES: I. Rapid Alterations in the Blood Sugar Level of Rabbits as Result of Intravenous Injections of Killed Bacteria of Various Types.
Eleazer et al. Clostridium perfringens infection in turkey poults
Goto et al. In vitro and in vitro evaluation of enduracidin, a new peptide antibiotic substance
GB1530476A (en) Method for the chilling storage of raw materials of fish and meat
Schriber et al. Use and toxicity of the colony-stimulating factors
GB1085956A (en) Improvements relating to vaccines
Arndt et al. Synergism between staphylococci and proteus in mixed infection.
Sahba et al. Synthetic and secretory effects of cholecystokinin-pancreozymin on the pigeon pancreas
ES467067A1 (es) Procedimiento para la preparacion de compuestos promotores de secrecion de insulina.
Johnson jr et al. Treatment of chronic typhoid carriers with ampicillin
GB1161722A (en) Improvements in or relating to the Preparation of Enzyme Solutions
ES275159A1 (es) Un proceso industrial de fermentaciën continua de acido lactico
GB1229189A (fr)
GB1114954A (en) Animal growth promoter
US2608480A (en) Preparation of vaccine manures for agricultural soils
Olitzki et al. Protective effect of cattle sera on white mice infected with Brucella abortus with the aid of the mucin technic
GB1380554A (en) Treatment of poultry
Izzo et al. Gonads and experimental tuberculosis
Bradham et al. A method of producing bacteremia in dogs
CS178535B1 (en) Method of stabilization of infusions,injections and other sterile preparationes of glucose or fructose-containing lactate or acetate or such preparationes with only fructose or invertose
FLORA EXPERIMENTAL STUDIES ON AMOEBIC LIVER ABSCESS
Waters et al. The effect of antitoxin on experimental infection with Clostridium novyi (oedematiens) in guinea pigs, with a note on active immunization
GB1291214A (en) Vaccine against typhoid fever and process for the production thereof
Douglas et al. Metaphen: II. Its Experimental Evaluation as an Antiseptic and Disinfectant

Legal Events

Date Code Title Description
ST Notification of lapse